NCT03297437

Brief Summary

The primary objective of this study is to identify predictors of neurofeedback training success.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

October 2, 2017

Status Verified

September 1, 2017

Enrollment Period

4 years

First QC Date

September 26, 2017

Last Update Submit

September 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • correlation between introspection scores and learning success

    The primary outcome measure is a correlation between introspection scores and neurofeedback learning success across all subjects.

    48 months

Interventions

In a neurofeedback setting, brain activity is measured non-invasively, the brain imaging data is analyzed in real-time, and then feedback regarding the current level of brain activity is provided to the subject.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 - 65 years. Magnetic resonance imaging compatibility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Psychiatry, University of Zurich

Zurich, Canton of Zurich, 8032, Switzerland

RECRUITING

Central Study Contacts

Frank Scharnowski, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

September 26, 2017

First Posted

September 29, 2017

Study Start

October 1, 2017

Primary Completion

September 30, 2021

Study Completion

September 30, 2021

Last Updated

October 2, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations